Oregon Health & Science University-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2018

  1. Targeting BCR-ABL-independent TKI resistance in chronic myeloid leukemia by mTOR and autophagy inhibition

    Journal of the National Cancer Institute, Vol. 110, Núm. 5, pp. 467-478